BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 8
• 9
• 10
• 11
• 12
• 15
• 16
• 17
• 18
• 19
• 21
• 22
• 23
• 24
• 25
• 26
• 29
• 30

• Pharm Country

  TransCelerate BioPharma Releases Recommended Approach For Protecting Personal Data In Clinical Study Reports

  September 2, 2014

   · 

  3 min read
• Drug Development

  VentiRx Pharmaceuticals, Inc. Announces Fast Track Designation Granted For Motolimod (VTX-2337), A Novel Immunotherapy For Women With Ovarian Cancer

  September 2, 2014

   · 

  3 min read
• BioForest

  VentiRx Pharmaceuticals, Inc. Provides Corporate And Clinical Update

  September 2, 2014

   · 

  3 min read
• Biotech Beach

  OncoSec Medical Inc. To Present At Five Events In September

  September 2, 2014

   · 

  1 min read
• Biotech Beach

  CytRx Corporation To Present At Upcoming Investor Conferences In New York City And Las Vegas

  September 2, 2014

   · 

  1 min read
• Biotech Bay

  Agilent Technologies Inc. Introduces Next-Generation Sequencing Cancer Research Panels

  September 2, 2014

   · 

  1 min read
• Pharm Country

  Daxor Corporation Announces Filing Of Form N-CSR For June 30, 2014

  September 2, 2014

   · 

  5 min read
• Biotech Beach

  Sequenom Inc. Announces Participation At The 2014 Morgan Stanley Global Healthcare Conference

  September 2, 2014

   · 

  1 min read
• Biotech Beach

  BioPhotas Announces The Launch Of The Celluma™ ELITE To The Aesthetic Physician Market

  September 2, 2014

   · 

  2 min read
• Drug Development

  F2G Ltd, The UK-Based Antifungal Drug Discovery And Development Company, Today Announces Commencement Of A Phase 1 Single Ascending Dose Study Of A Novel Antifungal Agent, F901318.

  September 2, 2014

   · 

  2 min read